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a b s t r a c t
Castleman’s disease (CD) is a polyclonal lymphoproliferative disorder also known as giant 
nodular hyperplasia or angiofollicular lymph node hyperplasia. It is a rare disease often 
associated to human immunodeficiency virus (HIV) and human herpes virus 8 (HHV-8). 
Histopathological findings in Castleman’s disease suggest an exaggerated response to an-
tigenic stimuli seen in other diseases associated with immune activation, such as rheu-
matoid arthritis. An important aspect of its pathogenesis is the autonomous production of 
interleukin-6 (IL-6). In this disease, the clinical manifestations are associated to IL-6 serum 
levels, and surgical removal of the compromised lymph nodes or use of anti-IL-6 antibodies 
can slow down the symptoms. We describe a multicentric Castleman’s disease in a young 
woman not associated to HHV-8 virus infection or immunosuppression. A short review of 
the literature follows the description of this clinical case.
© 2014 Sociedade Brasileira de Reumatologia. Published by Elsevier Editora Ltda. 
All rights reserved.
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Doença de Castleman multicêntrica não associada aos vírus HHV-8 e HIV
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r e s u m o
A doença de Castleman (DC) é uma desordem linfoproliferativa policlonal, também co-
nhecida como hiperplasia nodular gigante ou hiperplasia angiofolicular linfoide. Esta é 
uma doença rara que está frequentemente associada ao vírus da imunodeficiência hu-
mana (HIV) e ao herpes vírus 8 (HHV-8). Os achados histopatológicos encontrados na DC 
sugerem uma intensa resposta aos estímulos antigênicos observada em várias doenças 
associadas com ativação imune, como a artrite reumatoide. Um fator importante impli-
cado na patogênese da DC é a produção autônoma da interleucina-6 (IL-6). Nessa doença, 
as manifestações clínicas estão relacionadas aos níveis de IL-6, e a remoção cirúrgica dos 
linfonodos acometidos ou a utilização de anticorpos anti-IL-6 fazem regredir os sintomas. 
Descrevemos um caso da DC multicêntrica em uma mulher jovem, não associada à in-
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fecção pelo vírus HHV-8 ou à imunossupressão. Uma breve revisão da literatura se segue 
à descrição do caso clínico.
© 2014 Sociedade Brasileira de Reumatologia. Publicado por Elsevier Editora Ltda. 
Todos os direitos reservados.
Introduction
The lymphoid angiofollicular hyperplasia or Castleman’s dis-
ease (CD) was described in 1956 by Benjamin Castleman, who 
identified a number of patients with solitary and hyperplasic 
mediastinal lymph nodes containing follicles with interfollic-
ular vascular proliferation.1 After the discovery of herpes vi-
rus associated with Kaposi’s sarcoma (HHV-8) in HIV-positive 
patients and its identification in patients with CD, there was 
a real breakthrough in the understanding of disease patho-
genesis.2
CD is a rare disease and there are no reliable estimates 
of its incidence in the population. There are two clinical syn-
dromes: unicentric and multicentric. In the unicentric form, 
only one lymph node is affected, usually in the mediastinum, 
and the patient is clinically asymptomatic. In the multicentric 
form, the patient can present various clinical symptoms in-
cluding anaemia, fatigue, anorexia, night sweats, weight loss, 
fever and hepatosplenomegaly.3
The multicentric form is often associated with HHV-8 and 
HIV-1 viruses. In HIV-positive patients, the disease tends to 
be more aggressive, with intense constitutional symptoms, 
splenomegaly, generalized lymphadenopathy, pancytopenia, 
interstitial pneumonitis and increased incidence of Kaposi 
sarcoma.4 In the multicentric form, associated or not with 
HHV-8, there is an overproduction of IL-6 and a polyclonal 
proliferation of B lymphocytes.
These changes stimulate the onset of autoimmune mani-
festations, including POEMS (polyneuropathy, organomegaly, 
endocrinopathy, monoclonal gammopathy and skin changes) 
syndrome, and this complicates the diagnosis during the clin-
ical investigation of a connective tissue disease. By histologi-
cal analysis of lymph nodes, DC is classified in three forms: 
hyaline-vascular variant, plasmacytic variant, and a variant 
associated with HHV-8.
The hyaline-vascular form is characterized by separate 
follicles, with expansion of the mantle zone and presence of 
small lymphocytes forming concentric rings that surround 
the germinal center, which presents intense vascularization. 
The vascular proliferation also occurs among the follicles and 
there is often perivascular hyalinization.
In the plasmacytic form, a disruption of lymph node ar-
chitecture can be observed, with variable germinal center hy-
perplasia, expansion of the mantle zone and marked plasma-
cytosis. In the unicentric form, the hyaline-vascular variant 
constitutes the most common histologic pattern, and in the 
multicentric form the most frequent histologic pattern is the 
plasmacytic variant, which can be associated or not to HHV-8 
and to HIV-1.5 
The clinical and laboratory features of the two Castleman’s 
disease syndromes are compared in Table 1.
Case report
A woman, 31 years-old, dentist, sought medical attention due 
to complaints of fatigue, weakness and pallor occurring for 
over two years. Previous CBCs showed hypochromic micro-
cytic anaemia, detected since 1995. At that time, the patient 
showed hemoglobin 9.4 g/dL and hematocrit 30%, maintain-
ing similar levels throughout the years. Due to the detected 
anaemia, the patient sought the Haematology Service, where 
obtaining a definitive diagnosis was not possible.
As the patient had, in addition to anaemia, a positive test 
for antinuclear antibody (ANA) and tests showing evidence of 
inflammatory activity, she was referred to the Rheumatology 
Department in search of a possible autoimmune disease that 
could justify the clinical and laboratory findings.
On physical examination at admission, the patient was in 
good general condition, except for a slight pallor of mucous 
membranes. BP=110×70, afebrile and speaking clearly. Lungs 
without adventitious sounds and a rhythmic heart without 
murmurs. Ganglia, liver and spleen were not palpable.
The initial laboratory workup showed hypochromic mi-
crocytic anaemia with normal WBC and platelets. Serum iron 
and transferrin saturation were low.
Subsequent tests to clarify the cause of anaemia were nega-
tive, including: reticulocyte count, hemoglobin electrophoresis, 
sickling test, erythrocyte resistance to hypotonic solutions, co-
agulogram, folic acid, vitamin B12, glucose 6-phosphate dehy-
drogenase (G6PD), ceruloplasmin and aminolevulinic acid. All 
hormone levels were within normal limits. The protein elec-
trophoresis study showed an increase in α, β and γ globulin 
fractions. At the first evaluation, the following results were 
obtained: Erythrocyte Sedimentation Rate (ESR) 63 mm/h, 
Table 1 – Characteristics of Castleman disease variants
Unicentric Multicentric
Clinical picture Single 
asymptomatic 
mass 
Generalized 
lymphadenopathy, 
hepatosplenomegaly, fever
Laboratory 
abnormalities
Uncommon Anaemia, 
hypergammaglobulinemia, 
nESR 
Age group 15-30 years 50-65 years
Gender Men, in 60% Same
Histopathologic 
pattern
Hialinovascular 
(90%)
Plasmacytic or mixed (90%)
HHV-8 Rare Present in all patients HIV+
Present in 50% of patients 
HIV–
ESR – Erythrocyte Sedimentation Rate, HHV-8 – Herpes Virus 8, HIV 
– Human Immunodeficiency Virus
328 R E V  B R A S  R E U M A T O L .  2 0 1 4 ; 5 4 ( 4 ) : 3 2 6 – 3 2 9
C Reactive Protein (CRP) 19.2 mg/dL (Reference Value [RV] up to 
0.5 mg/dL), Complement fraction 3 (C3) 186 mg/dL (RV 90-189 
mg/dL) and total complement 426 mg/dL (RV 170-330 mg/dL).
Autoantibodies tests, including anti-Ro/SSA, anti-La/SSB, 
anti-native DNA, anti-Sm, anti-RNP, antineutrophil cytoplas-
mic antibodies (ANCA) and rheumatoid factor, were negative, 
with ANA 1/80 positive with a fine speckled pattern. The se-
rology for HIV, toxoplasmosis, Epstein-Barr virus and HHV-8 
was negative. Tests for anti-HBs and anti-herpes simplex virus 
(HSV) were positive and our patient reported an episode of oral 
herpes involvement and a previous vaccination against hepati-
tis B. The study of tumour markers was negative. Examinations 
of urine, faeces and cervical secretion showed no changes.
Thoracic radiographs and pelvic ultrasound showed no 
changes. An ultrasonography study of the abdomen revealed 
solid nodules: the smaller in the splenic hilum, measuring 2.8 
× 1.6cm, and the larger anterior to the left kidney and lateral 
to the tail of the pancreas, measuring 7.0 × 4.1 × 4.0cm.
The myelogram showed normocellular granulocytic, 
erythrocytic and megakaryocytic series, medullary iron ++ (RV 
++/+++), sideroblasts 5% (RV 30%), and ring sideroblasts ab-
sent – findings consistent with microcytic anaemia of chronic 
inflammation.
A magnetic nuclear resonance study of the abdomen 
showed multiple oval nodular images in the splenic hilum with 
1-3cm in diameter, not impregnated by the ferric contrast, and 
a solid mass of well-defined contours located medially to the 
inferior pole of the spleen, measuring approximately 6.0 × 4.5 × 
4.5cm. The gallium-67 scintigraphy showed anomalous and in-
tense hyperconcentration of the radiotracer in the topography 
of a solid mass at the lower pole of the spleen.
An ultrasound-guided fine needle aspiration (FNA) biopsy 
of an abdominal lymph node revealed cytological findings 
consistent with typical mature lymphoid and myeloid cells, 
which could correspond to an accessory spleen or to myeloid 
metaplasia. A bone marrow biopsy revealed hypocellular 
granulocytic, erythrocytic and megakaryocytic series and no 
granulomas, necrosis, amyloid or abnormal cells.
A videolaparoscopic surgery was performed with a biopsy 
of enlarged retrogastric lymph nodes and spleen chain. The 
pathologic examination of the specimens was consistent 
with the diagnosis of Castleman’s disease (plasmacytic vari-
ant) (Fig. 1).
In the case described, the patient was initially treated with 
corticosteroids, with no clinical response. On that occasion, 
tocilizumab (an anti-IL-6 receptor antibody) was not avail-
able for use in our country. Due to the chronic and persis-
tent inflammation, the patient developed renal amyloidosis, 
progressing to chronic renal failure. After a prolonged period 
on dialysis, the patient underwent renal transplantation and 
currently remains clinically well.
Discussion
In this paper, we describe the case of a young female patient 
with symptoms of fatigue on exertion, hypochromic micro-
cytic anaemia, tests of inflammatory activity persistently 
high and a positive ANA test. In principle, these findings could 
be consequent to a number of diseases, including SLE, and 
this was the reason for the referral of our patient to the De-
partment of Rheumatology.
Only after the completion of imaging studies (ultrasonog-
raphy, MRI and scintigraphy), our diagnostic reasoning sug-
gested lymphoproliferative or infectious disorders that could 
justify the laboratory changes and also the presence of mul-
tiple intra-abdominal nodules. Despite all clinical investiga-
tion, the diagnosis of CD was obtained only after the biopsy 
of abdominal nodes by videolaparoscopy, followed by histo-
pathological and immunohistochemical analysis.
The clinical and laboratory data of this patient can be ex-
plained by the biological actions of IL-6 overproduction in-
cluding anaemia and an increase of immunoglobulins and 
high inflammatory activity tests. Furthermore, IL-6 can in-
duce the formation of autoantibodies, thus justifying the pos-
itive ANA test.6 During the evolution of the clinical case, we 
could not obtain a value for serum IL-6 because this test was 
not yet standardized in our country.
The systemic involvement and the plasmacytic histologi-
cal presentation allowed us to classify our patient in CD’s 
multicentric form. The connective tissue diseases and the 
multicentric form of CD share many pathophysiological char-
acteristics, and this may cause diagnostic difficulties. A re-
view of the presence of autoimmune diseases concomitant to 
DC revealed an association with RA, Sjogren’s syndrome, my-
asthenia gravis, SLE/polymyositis overlap syndrome, mixed 
connective tissue disease and SLE.7
The rheumatologist should consider the investigation of 
a solitary DC or of DC in association with a connective tissue 
disease when his/her patient has additional clinical features 
not expected in his/her disease development, a persistence of 
symptoms and of constitutional signs unusual for a connec-
tive tissue disease, lymphadenomegaly on physical examina-
tion or on imaging studies, or if unexpected difficulties arise 
during his/her treatment.
Fig. 1 – Abdominal lymph node biopsy showed histological 
findings consistent with Castleman’s disease, plasmacytic 
variant. A) Lymphoid follicular hyperplasia with prominent 
germinal centers, B) Paracortical proliferated blood vessels 
with plump endotelial cells, C) Numerous expressing 
kappa and lambda immunoglobulin light chains.
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